InCephalo raises €2.3M Seed round
13 October 2023· Allschwil, Switzerland· health, oncology, biotech, b2b, deep_hardware
Awarded by the Eurostars program to a consortium led by InCephalo to accelerate its novel brain cancer drug candidate and study its effects on patient-tissue models.
Investors
LeadEurostars
About InCephalo
Stage
Seed
Headquarters
Allschwil, Switzerland
Founded
2021
Team Size
6–20
Sectors
healthoncologybiotechb2bdeep_hardware